Hepatoma Research

Hepatoma Research Received the First Impact Factor！

Hepatoma Research received its first impact factor of 1.7! It is ranked in the Q3 quartile within the field of Gastroenterology & Hepatology.

Hepatoma Research Achieves Significant Increase with a 2023 CiteScore of 3.2!

Hepatoma Research achieved a remarkable CiteScore of 3.2 for 2023, a significant improvement from 2.5 in 2022.

Welcome Six New Associate Chief Editors of Hepatoma Research

Hepatoma Research is delighted to announce the appointment of six world-renowned scientists to serve as Associate Chief Editors.

Introducing our new preprint platform, a fast and efficient way to share your research with the academic community.

We consistently welcome suggestions for improvements from both readers and authors (send an e-mail to preprint@scierxiv.com).

Hepatoma Research| 2024 Best Paper Awards

The Selection Committee of Hepatoma Research has identified five papers as exemplary contributions

Hepatoma Research 2023 Outstanding Reviewer Award Winners

This award commends individuals who have demonstrated exceptional commitment and made significant contributions to the rigorous peer-review process.

Hepatocellular carcinoma surveillance: current practice and future directions

Histopathology of hepatocellular carcinoma - when and what

Understanding immune perspectives and options for the use of checkpoint immunotherapy in HCC post liver transplant

Advances in Y-90 radioembolization for the treatment of hepatocellular carcinoma

Liver Transplantation for perihilar cholangiocarcinoma. Do we need to move forward?

Academic Talks

Lewis R. Roberts
Special Interview with Prof. Lewis R. Roberts from Mayo Clinic

NaN

Articles

Most Recent | Most Viewed | Most Downloaded

Contemporary perspectives on laparoscopic liver resection for hepatocellular carcinoma: unravelling the potential and limitations

Nikhil Suresh, ... Abdul Rahman Hakeem

Open Access Review DOI: 10.20517/2394-5079.2024.07 24 Jun 2024

Views: Downloads:

Download PDF

Pneumonia promotes pulmonary metastasis of HCC after transplantation via VEGF regulated PI3K/AKT/Cas-9 signaling and angiogenesis

Runzhou Zhuang, ... Xiao Xu

Open Access Original Article DOI: 10.20517/2394-5079.2024.50 23 Jun 2024

Views: Downloads:

Download PDF

RNA-based therapies in hepatocellular carcinoma: state of the art and clinical perspectives

Le Xing, ... Ming Liu

Open Access Review DOI: 10.20517/2394-5079.2024.25 19 Jun 2024

Views: Downloads:

Download PDF

Multidisciplinary treatment of hepatocellular carcinoma in 2023: Italian treatment guidelines

Piera Federico

, Bruno Daniele

Open Access Editorial DOI: 10.20517/2394-5079.2024.57 29 May 2024

Views: Downloads:

Download PDF

MASLD-mimicking microenvironment drives an aggressive phenotype and represses IDH2 expression in hepatocellular carcinoma

Peyda Korhan

, ... Neşe Atabey

Open Access Original Article DOI: 10.20517/2394-5079.2023.140 21 May 2024

Views: Downloads:

Download PDF

Most Cited Papers In Last Two Years

Hepatocellular carcinoma surveillance: current practice and future directions

Joseph C. Ahn, ... Ju Dong Yang

Open Access Review DOI: 10.20517/2394-5079.2021.131 10 Mar 2022

Views: Downloads:

Download PDF

The role of minimally invasive surgery in the treatment of HCC

Gianluca Cassese

, ... Roberto Ivan Troisi

Open Access Review DOI: 10.20517/2394-5079.2022.14 15 May 2022

Views: Downloads:

Download PDF

Epidemiology of cholangiocarcinoma

Federica Turati, ... Carlo La Vecchia

Open Access Original Article DOI: 10.20517/2394-5079.2021.130 11 Apr 2022

Views: Downloads:

Download PDF

Ongoing Special Issues

Topic: Multidisciplinary Management of HCC

Prof. Alessandro Vitale, MD, PhD

Submission Deadline: 30 Sep 2024

Published articles: 0

Topic: Current Strategies for the Treatment of Intermediate Hepatocellular Carcinoma

Prof. Francesco Tovoli, MD

Submission Deadline: 30 Sep 2024

Published articles: 0

Editorial Board

Partners

Data

2404

Authors

1012

Reviewers

2015

Published Since

For Authors

For Reviewers

Peer Review Guidelines

For Readers

Add your e-mail address to receive forthcoming Issues of this journal:

Topics Collection

Topic: Systemic Therapy for Advanced Cholangiocarcinoma: New Options on the Horizon

Topic: Molecular Pathogenesis and Drivers of Cholangiocarcinoma

Topic: Immunotherapy and Immunotherapy Biomarkers for Hepatocellular Carcinoma

Latest Issue

All Issues

Volume 9 (2023) (in progress)

Related Journals

Journal of Cancer Metastasis and Treatment

Metabolism and Target Organ Damage

Editor-in-Chief: Amedeo Lonardo

Announcement

AMMF's Hybrid 2024 European Cholangiocarcinoma Conference

News

Hepatoma Research Received Its First Impact Factor！

Hepatoma Research Achieves Significant Increase with a 2023 CiteScore of 3.2!

Hepatoma Research Received the First Impact Factor！

Hepatoma Research received its first impact factor of 1.7! It is ranked in the Q3 quartile within the field of Gastroenterology & Hepatology.

Hepatoma Research Achieves Significant Increase with a 2023 CiteScore of 3.2!

Hepatoma Research achieved a remarkable CiteScore of 3.2 for 2023, a significant improvement from 2.5 in 2022.

Welcome Six New Associate Chief Editors of Hepatoma Research

Hepatoma Research is delighted to announce the appointment of six world-renowned scientists to serve as Associate Chief Editors.

Introducing our new preprint platform, a fast and efficient way to share your research with the academic community.

We consistently welcome suggestions for improvements from both readers and authors (send an e-mail to preprint@scierxiv.com).

Hepatoma Research| 2024 Best Paper Awards

The Selection Committee of Hepatoma Research has identified five papers as exemplary contributions

Hepatoma Research 2023 Outstanding Reviewer Award Winners

This award commends individuals who have demonstrated exceptional commitment and made significant contributions to the rigorous peer-review process.

Lewis R. Roberts
Special Interview with Prof. Lewis R. Roberts from Mayo Clinic

NaN

Most Cited Papers In Last Two Years

Hepatocellular carcinoma surveillance: current practice and future directions

Joseph C. Ahn, ... Ju Dong Yang

Open Access | Review | 10 Mar 2022

Views: | Downloads:

Download PDF

The role of minimally invasive surgery in the treatment of HCC

Gianluca Cassese

, ... Roberto Ivan Troisi

Open Access | Review | 15 May 2022

Views: | Downloads:

Download PDF

Epidemiology of cholangiocarcinoma

Federica Turati, ... Carlo La Vecchia

Open Access | Original Article | 11 Apr 2022

Views: | Downloads:

Download PDF

Ongoing Special Issues

Topic: Multidisciplinary Management of HCC

Prof. Alessandro Vitale, MD, PhD

Submission Deadline: 30 Sep 2024

Published articles: 0

Topic: Current Strategies for the Treatment of Intermediate Hepatocellular Carcinoma

Prof. Francesco Tovoli, MD

Submission Deadline: 30 Sep 2024

Published articles: 0

Related Journals

Journal of Cancer Metastasis and Treatment

Metabolism and Target Organ Damage

Editor-in-Chief: Amedeo Lonardo

News

Hepatoma Research Received Its First Impact Factor！

Hepatoma Research Achieves Significant Increase with a 2023 CiteScore of 3.2!

Data

2404

Authors

1012

Reviewers

2015

Published Since

Hepatoma Research

Hepatocellular carcinoma surveillance: current practice and future directions

Histopathology of hepatocellular carcinoma - when and what

Understanding immune perspectives and options for the use of checkpoint immunotherapy in HCC post liver transplant

Advances in Y-90 radioembolization for the treatment of hepatocellular carcinoma

Liver Transplantation for perihilar cholangiocarcinoma. Do we need to move forward?

Lewis R. Roberts
Special Interview with Prof. Lewis R. Roberts from Mayo Clinic

Articles

Contemporary perspectives on laparoscopic liver resection for hepatocellular carcinoma: unravelling the potential and limitations

Pneumonia promotes pulmonary metastasis of HCC after transplantation via VEGF regulated PI3K/AKT/Cas-9 signaling and angiogenesis

RNA-based therapies in hepatocellular carcinoma: state of the art and clinical perspectives

Multidisciplinary treatment of hepatocellular carcinoma in 2023: Italian treatment guidelines

MASLD-mimicking microenvironment drives an aggressive phenotype and represses IDH2 expression in hepatocellular carcinoma

Hepatocellular carcinoma surveillance: current practice and future directions

The role of minimally invasive surgery in the treatment of HCC

Epidemiology of cholangiocarcinoma

Topic: Multidisciplinary Management of HCC

Topic: Current Strategies for the Treatment of Intermediate Hepatocellular Carcinoma

Journal of Cancer Metastasis and Treatment

Metabolism and Target Organ Damage

Hepatocellular carcinoma surveillance: current practice and future directions

Histopathology of hepatocellular carcinoma - when and what

Understanding immune perspectives and options for the use of checkpoint immunotherapy in HCC post liver transplant

Advances in Y-90 radioembolization for the treatment of hepatocellular carcinoma

Liver Transplantation for perihilar cholangiocarcinoma. Do we need to move forward?

Lewis R. Roberts
Special Interview with Prof. Lewis R. Roberts from Mayo Clinic

Topic: Multidisciplinary Management of HCC

Topic: Current Strategies for the Treatment of Intermediate Hepatocellular Carcinoma

Journal of Cancer Metastasis and Treatment

Metabolism and Target Organ Damage

Hepatoma Research Received Its First Impact Factor！

Hepatoma Research Achieves Significant Increase with a 2023 CiteScore of 3.2!

Portico

Portico

Hepatoma Research

Hepatocellular carcinoma surveillance: current practice and future directions

Histopathology of hepatocellular carcinoma - when and what

Understanding immune perspectives and options for the use of checkpoint immunotherapy in HCC post liver transplant

Advances in Y-90 radioembolization for the treatment of hepatocellular carcinoma

Liver Transplantation for perihilar cholangiocarcinoma. Do we need to move forward?

Lewis R. RobertsSpecial Interview with Prof. Lewis R. Roberts from Mayo Clinic

Articles

Contemporary perspectives on laparoscopic liver resection for hepatocellular carcinoma: unravelling the potential and limitations

Pneumonia promotes pulmonary metastasis of HCC after transplantation via VEGF regulated PI3K/AKT/Cas-9 signaling and angiogenesis

RNA-based therapies in hepatocellular carcinoma: state of the art and clinical perspectives

Multidisciplinary treatment of hepatocellular carcinoma in 2023: Italian treatment guidelines

MASLD-mimicking microenvironment drives an aggressive phenotype and represses IDH2 expression in hepatocellular carcinoma

Hepatocellular carcinoma surveillance: current practice and future directions

The role of minimally invasive surgery in the treatment of HCC

Epidemiology of cholangiocarcinoma

Topic: Multidisciplinary Management of HCC

Topic: Current Strategies for the Treatment of Intermediate Hepatocellular Carcinoma

Journal of Cancer Metastasis and Treatment

Metabolism and Target Organ Damage

Hepatocellular carcinoma surveillance: current practice and future directions

Histopathology of hepatocellular carcinoma - when and what

Understanding immune perspectives and options for the use of checkpoint immunotherapy in HCC post liver transplant

Advances in Y-90 radioembolization for the treatment of hepatocellular carcinoma

Liver Transplantation for perihilar cholangiocarcinoma. Do we need to move forward?

Lewis R. RobertsSpecial Interview with Prof. Lewis R. Roberts from Mayo Clinic

Topic: Multidisciplinary Management of HCC

Topic: Current Strategies for the Treatment of Intermediate Hepatocellular Carcinoma

Journal of Cancer Metastasis and Treatment

Metabolism and Target Organ Damage

Hepatoma Research Received Its First Impact Factor！

Hepatoma Research Achieves Significant Increase with a 2023 CiteScore of 3.2!

Portico

Portico

Lewis R. Roberts
Special Interview with Prof. Lewis R. Roberts from Mayo Clinic

Lewis R. Roberts
Special Interview with Prof. Lewis R. Roberts from Mayo Clinic